This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Shire Orphan Therapies Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Jochen Knolle: Innovator in Angiogenesis Inhibition
Introduction
Jochen Knolle is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical research, particularly in the area of angiogenesis inhibition. His work focuses on developing compounds that can effectively treat diseases where the inhibition of angiogenesis is crucial.
Latest Patents
Jochen Knolle holds one patent titled "Compounds for the inhibition of angiogenesis and use thereof." This invention is directed to compounds of structure (I), specifically compounds of structure (VIII) where the variables are defined in the description. These compounds serve as integrin inhibitors and are useful in treating diseases that require the inhibition of angiogenesis.
Career Highlights
Jochen Knolle is currently employed at Shire Orphan Therapies GmbH, where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, particularly those related to cancer and other angiogenesis-related diseases.
Collaborations
Some of his notable coworkers include Grit Zahn and Roland Stragies, who contribute to the innovative environment at Shire Orphan Therapies GmbH.
Conclusion
Jochen Knolle's contributions to the field of angiogenesis inhibition highlight his role as a significant inventor in medical research. His patented compounds offer promising avenues for treating critical diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile